ArticleCancer immunology research2026

CD4+ T Cells Mediate MHC-Deficient Tumor Rejection and Endothelial Cell Reprogramming.

Samuel I Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.